Change of Name

Recorded: 2016-02-25 Pages: 3

Assignor

IDEC PHARMACEUTICALS CORPORATION

Executed: 2003-11-12

Assignee

BIOGEN IDEC INC.

14 CAMBRIDGE CENTER, CAMBRIDGE, MASSACHUSETTS, 02142

Covered Property (1)

Use of Chimeric Anti-CD20 Antibody as in Vitro or in Vivo Purging Agent in Patients Receiving Bmt or Pbsc Transplant

Application: 14/154,956 →

Publication: US 2014/0363424

Related Assignments (2)

Other recorded transfers of the patent in this record — the chain of ownership.